Results for tag: "Sensorineural Hearing Loss Drug"

Sensorineural Hearing Loss (SNHL) is a type of hearing loss caused by damage to the inner ear or auditory nerve. It is the most common type of hearing loss and is usually permanent. SNHL is typically treated with hearing aids, cochlear implants, and other assistive devices. In some cases, drugs may be used to treat SNHL. Central Nervous System (CNS) drugs are used to treat a variety of conditions, including SNHL. These drugs are designed to target the auditory nerve and inner ear, and can help improve hearing in some cases. Common CNS drugs used to treat SNHL include corticosteroids, anticonvulsants, and anti-inflammatory drugs. These drugs can help reduce inflammation and improve nerve function, which can help improve hearing. The Sensorineural Hearing Loss Drug market is a rapidly growing sector of the CNS drug market. Companies in this market are focused on developing drugs to treat SNHL, as well as other hearing-related conditions. Some of the major companies in this market include GlaxoSmithKline, Novartis, Pfizer, Merck, and Sanofi. Show Less Read more